All Stories

  1. Impact of HIV-1 infection pathways on susceptibility to antiviral drugs and on virus spread
  2. Identification of anti-HIV agents with a novel benzo[4,5]isothiazolo[2,3-a]pyrimidine scaffold
  3. Structure–activity relationship study of phenylpyrazole derivatives as a novel class of anti-HIV agents
  4. Design and synthesis of biotin- or alkyne-conjugated photoaffinity probes for studying the target molecules of PD 404182
  5. Mechanism of resistance to S138A substituted enfuvirtide and its application to peptide design
  6. Comprehensive In Vitro Analysis of Simian Retrovirus Type 4 Susceptibility to Antiretroviral Agents
  7. Structure–activity relationship study of pyrimido[1,2-c][1,3]benzothiazin-6-imine derivatives for potent anti-HIV agents
  8. CXCR4 Stimulates Macropinocytosis: Implications for Cellular Uptake of Arginine-Rich Cell-Penetrating Peptides and HIV
  9. Concise synthesis and anti-HIV activity of pyrimido[1,2-c][1,3]benzothiazin-6-imines and related tricyclic heterocycles
  10. Potent CXCR4 Antagonists Containing Amidine Type Peptide Bond Isosteres
  11. Characterization of HIV-1 resistance to a fusion inhibitor, N36, derived from the gp41 amino-terminal heptad repeat
  12. Synonymous mutations in stem-loop III of Rev responsive elements enhance HIV-1 replication impaired by primary mutations for resistance to enfuvirtide
  13. Elvitegravir: a new HIV integrase inhibitor
  14. Elvitegravir: an emerging HIV integrase inhibitor
  15. Broad Antiretroviral Activity and Resistance Profile of the Novel Human Immunodeficiency Virus Integrase Inhibitor Elvitegravir (JTK-303/GS-9137)